Retrospective study develops models for predicting HER-2 and Ki-67 in breast cancer, highlighting potential for personalized treatment.
Motivation: There is an urgent need to find a non-invasive method that can accurately predict HER-2 and Ki-67 expression status in breast cancer. Goal(s): Establishment of multiparametric MRI intratumor combined with peritumor radiomics models for preoperative prediction of HER-2 and Ki-67 expression status in breast cancer. Approach: A two-center retrospective study. Results: A random forest (RF) machine learning algorithm was used to construct eight radiomics models for preoperative predict HER-2 and Ki-67 expression status in breast cancer: intratumoral radiomics models, intratumoral combined with peritumoral (3-mm) radiomics models, and multisequence fusion radiomics models. Impact: Accurate preoperative prediction of HER-2 and Ki-67 expression status in breast cancer is expected to provide a reference for precise and personalized treatment decisions in later stages of clinical practice.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: